Exploring Cultural and Religious Effects on HPV Vaccination Decision Making Using a Web-Based Decision Aid: A Quasi-experimental Study

Abstract

Background

Human papillomavirus (HPV) poses a significant public health concern, as it is linked to various serious health conditions such as cancer and genital warts. Despite the vaccine’s safety, efficacy, and availability through national school programs, HPV vaccination rates remain low in Israel, particularly within the ultra-Orthodox community due to religious and cultural barriers. Decision aids have shown promise in facilitating shared decision making and promoting informed choices in health care. This study aimed to assess the impact of a novel Web-based decision aid on HPV vaccination intentions, knowledge, decision self-efficacy, and decisional conflict among Israeli parents and young adults, with a specific focus on exploring differences between religious groups.

Methods

Two Web-based decision aids were developed for parents of children aged 10 to 17 y (n = 120) and young adults aged 18 to 26 y (n = 160). A quasi-experimental study was conducted among Hebrew-speaking parents and young adults eligible for HPV vaccination. Participants completed pre- and postintervention questionnaires assessing vaccination intentions, knowledge about HPV, decision self-efficacy, and decisional conflict.

Results

The decision aid significantly improved intentions toward HPV vaccination among most religious groups, except the Jewish ultra-Orthodox community. Ultra-Orthodox participants exhibited reluctance to vaccinate themselves or their children (odds ratio [OR] = 0.23, P < 0.001 for parents’ group; OR = 0.43, P < 0.001 for young adults’ group). Parental preference for vaccinating girls over boys (OR = 2.66, P < 0.001) and increased inclination for vaccination among Muslim-Arabs were observed (OR = 3.12, P < 0.001). Knowledge levels improved among ultra-Orthodox participants but not decisional conflict and self-efficacy.

Conclusions

The Web-based decision aid positively influenced the quality of HPV vaccination decision making among various religious groups in Israel, except for the ultra-Orthodox community. Culturally tailored approaches that address specific community concerns are essential for informed decision making.

Highlights

Human papillomavirus (HPV) vaccination rates in Israel are substantially lower than those of other routine vaccinations, particularly among religious and ultra-Orthodox communities, largely due to sociocultural beliefs and misinformation.

A newly developed Web-based decision aid was implemented in a study involving parents and young adults to evaluate its impact on vaccination intent, knowledge about HPV, decision self-efficacy, and decisional conflict.

While the decision aid significantly enhanced vaccination intention, knowledge, and perceived behavioral control among various religious groups, it did not yield the same outcomes within the ultra-Orthodox Jewish community.

This study highlights the vital role of cultural adaptation in HPV vaccine decision aids within Israel, revealing significant disparities in vaccination perceptions and decisions among diverse religious and cultural groups.

Keywords

human papillomavirus (hpv)hpv vaccination decision aid ultra-orthodox community shared decision making decision self-efficacy decisional conflict vaccination intentions

Get full access to this article

View all access options for this article.

References

Harper

DeMars

LR.

HPV vaccines—a review of the first decade. Gynecol Oncol. 2017;146:196–204.

Shavit

Roura

Barchana

Diaz

Bornstein

Burden of human papillomavirus infection and related diseases in Israel. Vaccine. 2013;31(suppl 8):132–41. DOI: 10.1016/j.vaccine.2013.05.108

Levy

The importance of HPV testing for cervical cancer screening in Israel. Isr Med Assoc J. 2017;19(10):644–5.

Strategic Advisory Group of Experts (SAGE) on Immunization. Strategic Advisory Group of Experts (SAGE) Working Group on potential contribution of HPV vaccines and immunization towards cervical cancer elimination. 2022April:1–78. Available from: https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/human-papillomavirus-(hpv)/hpv-background-document–report-march-2022.pdf?sfvrsn=b600e252_1

Bruni

Diaz

Barrionuevo-Rosas

, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–63.

Khamisy-Farah

Adawi

Jeries-Ghantous

, et al. Knowledge of human papillomavirus (HPV), attitudes and practices towards anti-HPV vaccination among Israeli pediatricians, gynecologists, and internal medicine doctors: development and validation of an ad hoc questionnaire. Vaccines. 2019;7(4):157.

Shavit

Raz

Stein

, et al. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer. Appl Health Econ Health Policy. 2012;10(2):87–97.

Elran

Yaari

Glazer

Honovich

Grotto

Anis

Parents’ perceptions of childhood immunization in Israel: information and concerns. Vaccine. 2018;36(52):8062–8. DOI: 10.1016/j.vaccine.2018.10.078

Bassal

Schejter

Bachar

, et al. Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel. Arch Gynecol Obstet. 2015;292(2):405–13.

10.

Fisher

Laniado

Shoval

Hakim

Bornstein

Barriers to human papillomavirus vaccine acceptability in Israel. Vaccine. 2013;31(suppl 8):153–7. DOI: 10.1016/j.vaccine.2013.06.107

11.

Velan

Vaccine hesitancy as self-determination: an Israeli perspective. Isr J Health Policy Res. 2016;5(1):5–10. DOI: 10.1186/s13584-016-0071-x

12.

Wortsman

Glaser Chodik

Chodick

Correlations of HPV vaccine uptake among eight-grade students in Israel: the importance of ethnicity and level of religious observance. Women Heal. 2023;63(6):464–72. DOI: 10.1080/03630242.2023.2223721

13.

Redd

Jensen

Hughes

, et al. Effects of religious practice and teachings about sexual behavior on intent to vaccinate against human papillomavirus. Vaccines. 2022;10(3):397.

14.

Central Bureau of Statistics. Population of Israel on the Eve of 2023. 2023. Available from: https://www.cbs.gov.il/en/mediarelease/pages/2022/population-of-israel-on-the-eve-of-2023.aspx [Accessed 18 July, 2023].

15.

Shahbari

NAE

Gesser-Edelsburg

Davidovitch

Brammli-Greenberg

Grifat

Mesch

. Factors associated with seasonal influenza and HPV vaccination uptake among different ethnic groups in Arab and Jewish society in Israel. Int J Equity Health. 2021;20(1):1–17.

16.

Vidal

Shochat

Early to bed, early to rise: sleep perceptions, patterns and related behaviors in ultra-orthodox Jewish adolescents in Israel. Sleep Heal. 2017;3(6):458–64. DOI: 10.1016/j.sleh.2017.08.002

17.

Keshet

Popper-Giveon

“I took the trouble to make inquiries, so I refuse to accept your instructions”: religious authority and vaccine hesitancy among ultra-Orthodox Jewish mothers in Israel. J Relig Health. 2021;60(3):1992–2006. DOI: 10.1007/s10943-020-01122-4

18.

Shahbari

NAE

Gesser-Edelsburg

Mesch

. Case of paradoxical cultural sensitivity: mixed method study of web-based health informational materials about the human papillomavirus vaccine in Israel. J Med Internet Res. 2019;21(5):1–19.

19.

Highet

Jessiman-Perreault

Hilton

Law

Allen-Scott

. Understanding the decision to immunize: insights into the information needs and priorities of people who have utilized an online human papillomavirus (HPV) vaccine decision aid tool. Can J Public Heal. 2021;112(2):191–8.

20.

Elwyn

Edwards

Kinnersley

Grol

Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. Br J Gen Pract. 2000;50(460):892–7.

21.

Miron-Shatz

Golan

Brezis

Siegal

Doniger

GM.

Shared decision-making in Israel: status, barriers, and recommendations. Isr J Health Policy Res. 2012;1(1):1–8.

22.

Scalia

Durand

Elwyn

Shared decision-making interventions: an overview and a meta-analysis of their impact on vaccine uptake. J Intern Med. 2022;291(4):408–25.

23.

Stacey

Légaré

Lewis

, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;2017(4):CD001431.

24.

Wieringa

Rodriguez-Gutierrez

Spencer-Bonilla

, et al. Decision aids that facilitate elements of shared decision making in chronic illnesses: a systematic review. Syst Rev. 2019;8(1):1–9.

25.

Stacey

Légaré

Boland

, et al. 20th Anniversary Ottawa decision support framework: part 3 overview of systematic reviews and updated framework. Med Decis Making. 2020;40(3):379–98.

26.

Martin

Brogård Andersen

O’Brien

, et al. Providing balanced information about options in patient decision aids: an update from the international patient decision aid standards. Med Decis Making. 2021;41(7):780–800.

27.

Chenel

Mortenson

Guay

Jutai

Auger

Cultural adaptation and validation of patient decision aids: a scoping review. Patient Prefer Adherence. 2018;12:321–32.

28.

Elwyn

O’Connor

Stacey

, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417–9.

29.

Sepucha

Abhyankar

Hoffman

, et al. Standards for UNiversal reporting of Patient Decision Aid evaluation studies: the development of SUNDAE Checklist. BMJ Qual Saf. 2018;27(5):380–8.

30.

Gendler

Development and appraisal of a web-based decision aid for HPV vaccination for young adults and parents of children in Israel—a quasi-experimental study. Vaccines. 2023;11(6):1038.

31.

Shah

SFA

Ginossar

Bentley

Zimet

McGrail

. Using the theory of planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama. Vaccine. 2021;39(51):7421–8. DOI: 10.1016/j.vaccine.2021.10.082

32.

Ajzen

Constructing a theory of planned behavior questionnaire. Biofeedback and selfregulation. 2010;17:1–7. Available from: http://www.people.umass.edu/aizen/tpb.html

33.

Askelson

Campo

Lowe

Smith

Dennis

Andsager

Using the theory of planned behavior to predict mothers’ intentions to vaccinate their daughters against HPV. J Sch Nurs. 2010;26(3):194–202.

34.

Garvelink

Boland

Klein

, et al. Decisional conflict scale findings among patients and surrogates making health decisions: part II of an anniversary review. Med Decis Making. 2019;39(4):315–26.

35.

O’Connor

AM.

Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25–30. DOI: 10.1177/0272989X9501500105

36.

O’Connor

AM.

Sample Tool: Decision Self-Efficacy Scale. 1995. Available from: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_SelfEfficacy.pdf

37.

Stein Zamir

Israeli

. Knowledge, attitudes and perceptions about routine childhood vaccinations among Jewish ultra-Orthodox mothers residing in communities with low vaccination coverage in the Jerusalem district. Matern Child Health J. 2017;21(5):1010–7.

38.

Zach

Bentwich

ME.

Reasons for and insights about HPV vaccination refusal among ultra-Orthodox Jewish mothers. Dev World Bioeth. 2023;23(4):300–11.

39.

Jacobson

Spitzer

Gorelik

Edelstein

Barriers and enablers to vaccination in the ultra-orthodox Jewish population: a systematic review. Front Public Health. 2023;11:1244368.

40.

Velan

Yadgar

On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society. Isr J Health Policy Res. 2017;6(1):1–12.

41.

Juraskova

O’Brien

Mullan

Bari

Laidsaar-Powell

McCaffery

HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm. Int J Behav Med. 2012;19(4):518–25.

42.

Lahijani

King

Gullatte

Hennink

Bednarczyk

RA.

HPV vaccine promotion: the church as an agent of change. Soc Sci Med. 2021;268:113375. DOI: 10.1016/j.socscimed.2020.113375

43.

Fader

Ultra-Orthodox Jewish interiority, the Internet, and the crisis of faith. HAU. 2017;7(1):185–206.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB